Fibrodysplasia Ossificans Progressiva

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2021-11-01
Clinical Trial Update: Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP) [Phase 3]
Phase 3 trial evaluating garetosmab in Japanese adults with fibrodysplasia ossificans progressiva was withdrawn.